AXSOME THERAPEUTICS INC. - COMMON STOCK
98.62
14-نوفمبر-24 09:34:54
15 متأخرة بدقائق
الأسهم
+0.79
+0.81%
نطاق اليوم
96.80 - 99.67
ISIN
N/A
المصدر
NASDAQ
-
Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting
29 سبتمبر 2022 06:28:00 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
21 سبتمبر 2022 06:00:00 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Cowen 2nd Annual Novel Mechanisms in Neuropsychiatry Summit
14 سبتمبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics Initiates ADVANCE-2 Phase 3 Trial of AXS-05 in Alzheimer’s Disease Agitation
08 سبتمبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
06 سبتمبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
01 سبتمبر 2022 06:00:00 بحسب Nasdaq GlobeNewswire
-
19 أغسطس 2022 05:45:03 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
09 أغسطس 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022
28 يوليو 2022 06:00:02 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics Hosts Sunosi® Investor Update Virtual Event Today with Key Opinion Leaders
28 يونيو 2022 06:00:00 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics to Host Sunosi® Investor Update Virtual Event
22 يونيو 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
02 يونيو 2022 06:00:01 بحسب Nasdaq GlobeNewswire
-
31 مايو 2022 06:39:37 بحسب Nasdaq GlobeNewswire
-
09 مايو 2022 07:57:19 بحسب Nasdaq GlobeNewswire
-
28 مارس 2022 05:00:00 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics to Participate in the 1st Annual Needham Virtual Neuroscience Forum
11 مارس 2022 06:00:00 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Cowen 42nd Annual Health Care Conference
02 مارس 2022 06:00:01 بحسب Nasdaq GlobeNewswire